These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4896410)

  • 41. Effects of clonidin and chlorthalidone on blood pressure and glucose tolerance in hypertensive patients.
    Sung PK; Samet P; Yeh BK
    Curr Ther Res Clin Exp; 1971 May; 13(5):280-5. PubMed ID: 4998390
    [No Abstract]   [Full Text] [Related]  

  • 42. [The effect of an imidazole derivative on arterial blood pressure, hemodynamics and ventilation].
    Kochsiek K; Fritsche H
    Arzneimittelforschung; 1966 Sep; 16(9):1154-60. PubMed ID: 6014733
    [No Abstract]   [Full Text] [Related]  

  • 43. Clinical evaluation of the antihypertensive effects of debrisoquin, a new postganglionic vasodepressor agent.
    Talbot FJ
    Med Ann Dist Columbia; 1965 Dec; 34(12):580-3. PubMed ID: 5321849
    [No Abstract]   [Full Text] [Related]  

  • 44. [Medico-social aspects of arterial hypertension and clinical considerations on its treatment with the guanoxane-polythiazide combination].
    Di Benedetto A; Di Blasi S
    Minerva Med; 1967 Mar; 58(21):893-6. PubMed ID: 6026542
    [No Abstract]   [Full Text] [Related]  

  • 45. [Comparative assessment of the results of new antihypertensive drugs].
    Schubert R; Pasz T; Lindner O
    Munch Med Wochenschr; 1968 Jul; 110(27):1604-9. PubMed ID: 5756285
    [No Abstract]   [Full Text] [Related]  

  • 46. Debrisoquin sulfate: a clinical evaluation of a new antihypertensive agent.
    Blechman M; Sokol C; Moser M
    Curr Ther Res Clin Exp; 1969 Feb; 11(2):71-6. PubMed ID: 4975816
    [No Abstract]   [Full Text] [Related]  

  • 47. [On the evaluation of therapeutic effects in hypertension (described by the example of Guanoxan)].
    Siedek H; Klein K; Grübl M
    Munch Med Wochenschr; 1965 Oct; 107(43):2119-24. PubMed ID: 5899029
    [No Abstract]   [Full Text] [Related]  

  • 48. [On the therapy of hypertension with an imidazoline derivative].
    Krause W; Krämer D; Grünitz B
    Med Klin; 1969 Jul; 64(28):1274-6. PubMed ID: 5799785
    [No Abstract]   [Full Text] [Related]  

  • 49. [A clinical trial of guanoxabenz: a hypotensive agent with central and hypertensive action (author's transl)].
    Ledoux F; Welsch M; Steimer C; Schwartz J
    Therapie; 1981; 36(2):187-91. PubMed ID: 7027519
    [No Abstract]   [Full Text] [Related]  

  • 50. Preliminary experience with a new postganglion-blocking agent for the management of hypertension.
    Belle MS; Gilmore HR; Keyes MH; Sanford H
    J Fla Med Assoc; 1968 Dec; 55(12):1081-4. PubMed ID: 4881916
    [No Abstract]   [Full Text] [Related]  

  • 51. [ECG studies following oral administration of a new antihypertensive substance (Catapresan)].
    Strössenreuther H
    Med Monatsschr; 1966 Dec; 20(12):565-6. PubMed ID: 5980274
    [No Abstract]   [Full Text] [Related]  

  • 52. Tiamenidine, a centrally acting antihypertensive drug in essential hypertension [proceedings].
    Zamboulis C; Hossmann V; Dollery CT; Eckert H
    Br J Clin Pharmacol; 1979 Oct; 8(4):390P. PubMed ID: 508528
    [No Abstract]   [Full Text] [Related]  

  • 53. [Clinical studies on the treatment of hypertension using Disotat].
    Fröhling P; Kautzsch G
    Z Arztl Fortbild (Jena); 1977 Jan; 71(1):13-6. PubMed ID: 324148
    [No Abstract]   [Full Text] [Related]  

  • 54. [On the antihypertensive activity of some drugs alone or in various associations].
    Anfossi F; Guaraggi A; Rossi PL
    Minerva Cardioangiol; 1966 Oct; 14(10):617-22. PubMed ID: 5996323
    [No Abstract]   [Full Text] [Related]  

  • 55. [Treatment of severe hypertension with Catapresan. A comparative study of the effects of Catapresan and methyldopa on ambulant hypertensive patients].
    Becker-Christensen F; Bang HO; Ditzel J
    Ugeskr Laeger; 1970 Dec; 132(49):2331-6. PubMed ID: 5488234
    [No Abstract]   [Full Text] [Related]  

  • 56. [Controllable hypertension therapy with Tadip].
    Schütz E
    Med Klin; 1971 Jan; 66(4):121-6. PubMed ID: 5546736
    [No Abstract]   [Full Text] [Related]  

  • 57. [Moxonidine. A new antihypertensive agent of central action].
    Leães CG; Rosito GA
    Arq Bras Cardiol; 1998 Jun; 70(6):443-8. PubMed ID: 9713089
    [No Abstract]   [Full Text] [Related]  

  • 58. [Effect of prolonged treatment with 2-(2,6-dichlorophenylamine)-2-imidazoline HCl on renal hemodynamics in arterial hypertension].
    Ludwig H
    Arzneimittelforschung; 1968 May; 18(5):600-4. PubMed ID: 5755891
    [No Abstract]   [Full Text] [Related]  

  • 59. [Use of new hypotensive agent esbatal for treatment of the patients with hypertension].
    Borisenko AP
    Vrach Delo; 1967 Feb; 2():138-40. PubMed ID: 5617007
    [No Abstract]   [Full Text] [Related]  

  • 60. Trial of a new hypotensive drug--clonidine ("catapres").
    Trinker FR; Barnett AJ
    Med J Aust; 1970 Oct; 2(15):975-8. PubMed ID: 4920641
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.